Harel Insurance Investments & Financial Services Ltd. Purchases 2,509 Shares of Axon Enterprise, Inc. (NASDAQ:AXON)

Harel Insurance Investments & Financial Services Ltd. lifted its stake in Axon Enterprise, Inc. (NASDAQ:AXON) by 492.9% in the 2nd quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The institutional investor owned 3,018 shares of the biotechnology company’s stock after purchasing an additional 2,509 shares during the period. Harel Insurance Investments & Financial Services Ltd.’s holdings in Axon Enterprise were worth $888,000 at the end of the most recent reporting period.

Other large investors have also recently made changes to their positions in the company. Avantax Advisory Services Inc. lifted its holdings in shares of Axon Enterprise by 0.8% in the first quarter. Avantax Advisory Services Inc. now owns 5,302 shares of the biotechnology company’s stock worth $1,659,000 after buying an additional 40 shares in the last quarter. Brookstone Capital Management grew its position in Axon Enterprise by 5.1% in the 1st quarter. Brookstone Capital Management now owns 839 shares of the biotechnology company’s stock valued at $263,000 after acquiring an additional 41 shares during the last quarter. Envestnet Portfolio Solutions Inc. raised its position in Axon Enterprise by 1.1% during the 4th quarter. Envestnet Portfolio Solutions Inc. now owns 3,997 shares of the biotechnology company’s stock valued at $1,033,000 after purchasing an additional 43 shares in the last quarter. CWM LLC lifted its stake in Axon Enterprise by 1.5% in the second quarter. CWM LLC now owns 2,820 shares of the biotechnology company’s stock worth $830,000 after acquiring an additional 43 shares during the period. Finally, Burns Matteson Capital Management LLC boosted its stake in shares of Axon Enterprise by 6.7% during the second quarter. Burns Matteson Capital Management LLC now owns 730 shares of the biotechnology company’s stock valued at $215,000 after purchasing an additional 46 shares in the last quarter. 79.08% of the stock is owned by hedge funds and other institutional investors.

Insider Activity

In related news, Director Matthew R. Mcbrady sold 2,000 shares of Axon Enterprise stock in a transaction on Friday, August 9th. The shares were sold at an average price of $364.66, for a total value of $729,320.00. Following the completion of the sale, the director now owns 4,892 shares of the company’s stock, valued at approximately $1,783,916.72. The transaction was disclosed in a document filed with the SEC, which can be accessed through the SEC website. In other Axon Enterprise news, Director Julie A. Cullivan sold 993 shares of the business’s stock in a transaction that occurred on Friday, May 31st. The stock was sold at an average price of $281.72, for a total value of $279,747.96. Following the sale, the director now owns 4,553 shares in the company, valued at approximately $1,282,671.16. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available at this hyperlink. Also, Director Matthew R. Mcbrady sold 2,000 shares of the business’s stock in a transaction that occurred on Friday, August 9th. The stock was sold at an average price of $364.66, for a total value of $729,320.00. Following the transaction, the director now directly owns 4,892 shares in the company, valued at $1,783,916.72. The disclosure for this sale can be found here. Insiders sold 3,471 shares of company stock worth $1,145,795 over the last quarter. Corporate insiders own 6.10% of the company’s stock.

Analysts Set New Price Targets

A number of brokerages have commented on AXON. Robert W. Baird lifted their price target on Axon Enterprise from $355.00 to $360.00 and gave the stock an “outperform” rating in a research report on Wednesday, August 7th. Needham & Company LLC reiterated a “buy” rating and issued a $400.00 price target on shares of Axon Enterprise in a report on Wednesday, August 7th. Northland Securities lifted their price objective on shares of Axon Enterprise from $330.00 to $365.00 and gave the company an “outperform” rating in a research note on Thursday, August 8th. Craig Hallum increased their price objective on shares of Axon Enterprise from $370.00 to $376.00 and gave the stock a “buy” rating in a research note on Wednesday, August 7th. Finally, JMP Securities restated a “market outperform” rating and set a $375.00 target price on shares of Axon Enterprise in a research report on Wednesday, August 7th. Two equities research analysts have rated the stock with a hold rating and thirteen have issued a buy rating to the stock. According to MarketBeat, the company currently has an average rating of “Moderate Buy” and an average target price of $358.08.

Axon Enterprise Stock Down 0.4 %

AXON traded down $1.57 during trading on Tuesday, hitting $371.50. The company had a trading volume of 71,235 shares, compared to its average volume of 522,418. The company has a debt-to-equity ratio of 0.35, a current ratio of 2.88 and a quick ratio of 2.52. The business has a 50-day moving average of $311.77 and a 200-day moving average of $301.87. Axon Enterprise, Inc. has a 1-year low of $189.12 and a 1-year high of $378.25. The company has a market cap of $28.07 billion, a PE ratio of 109.08, a P/E/G ratio of 9.93 and a beta of 0.95.

Axon Enterprise (NASDAQ:AXON) last posted its quarterly earnings data on Tuesday, August 6th. The biotechnology company reported $1.20 earnings per share (EPS) for the quarter, beating the consensus estimate of $1.02 by $0.18. Axon Enterprise had a net margin of 16.06% and a return on equity of 9.34%. The business had revenue of $504.00 million during the quarter, compared to analysts’ expectations of $478.35 million. During the same period last year, the firm posted $0.80 earnings per share. The business’s revenue was up 34.5% on a year-over-year basis. As a group, analysts forecast that Axon Enterprise, Inc. will post 1.79 earnings per share for the current year.

About Axon Enterprise

Axon Enterprise, Inc develops, manufactures, and sells conducted energy devices (CEDs) under the TASER brand in the United States and internationally. It operates through two segments, Software and Sensors, and TASER. The company also offers hardware and cloud-based software solutions that enable law enforcement to capture, securely store, manage, share, and analyze video and other digital evidence.